Role of the dopaminergic system in the development of myopia in children and adolescents

Journal of Child Neurology

Volumn 29, Issue 12, 2014, Pages 1739-1746

  Nebbioso, Marcella ^a   Plateroti, Andrea Maria ^a   Pucci, Bruna ^a   Pescosolido, Nicola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Axial growth; Dopamine; Form deprivation myopia; Lens induced myopia; Phenylethylamine

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROTRANSMITTER; PHENETHYLAMINE; DOPAMINE RECEPTOR; MELATONIN; PHENETHYLAMINE DERIVATIVE;

BIOSYNTHESIS; CIRCADIAN RHYTHM; DISEASE COURSE; DOPAMINERGIC SYSTEM; HUMAN; LIGHT ADAPTATION; MYOPIA; NONHUMAN; PATHOPHYSIOLOGY; PRECURSOR; PRIORITY JOURNAL; RETINA; REVIEW; ADOLESCENT; CHEMISTRY; CHILD; FEMALE; MALE; METABOLISM; PATHOLOGY;

ADOLESCENT; CHILD; DOPAMINE; FEMALE; HUMANS; MALE; MELATONIN; MYOPIA; PHENETHYLAMINES; RECEPTORS, DOPAMINE; RETINA;

EID: 84919646059     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073814538666     Document Type: Review

References (88)

1. Feldkamper M, Schaeffel F. Interactions of genes and environment in myopia. Dev Ophthalmol. 2003;37:34-49.
2. Donovan L, Sankaridurg P, Ho A, et al. Myopia progression rates in urban children wearing single-vision spectacles. Optom Vis Sci. 2012;89:27-32.
3. Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the U.S. between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009;127:1632-1639.
4. Vingolo EM, Salvatore S, Domanico D, et al. Visual rehabilitation in patients with myopic maculopathy: our experience. Can J Ophthalmol. 2013;48:438-442.
5. Cui D, Trier K, Ribel-Madsen SM. Effect of day length on eye growth, myopia progression, and change of corneal power in myopic children. Ophthalmology. 2013;120:1074-1079.
6. Jacobi FK, Zrenner E, Broghammer M, Pusch CM. A genetic perspective on myopia. Cell Mol Life Sci. 2005;62:800-808.
7. Young TL, Metlapally R, Shay AE. Complex trait genetics of refractive error. Arch Ophthalmol. 2007;125:38-48.
8. Sundin OH, Leppert GS, Silva ED, et al. Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzledrelated protein. Proc Natl Acad Sci U S A. 2005;102:9553-9558.
9. Cheng CY, Huang W, Su KC, et al. Myopization factors affecting urban elementary school students in Taiwan. Optom Vis Sci. 2013; 90:400-406.
10. Saw SM, Chua WH, Hong A, et al. Nearwork in early-onset myopia. Invest Ophthalmol Vis Sci. 2002;43:332-339.
11. Cordain L, Eaton SB, Brand Miller J, et al. An evolutionary analysis of the aetiology and pathogenesis of juvenile-onset myopia. Acta Ophthalmol Scand. 2002;80:125-135.
12. Wu PC, Tsai CL, Wu HL, et al. Outdoor activity during class recess reduces myopia onset and progression in school children. Ophthalmology. 2013;120:1080-1085.
13. Jones LA, Sinnott LT, Mutti DO, et al. Parental history of myopia, sports and outdoor activities, and future myopia. Invest Ophthalmol Vis Sci. 2007;48:3524-3532.
14. Iuvone PM, Tigges M, Stone RA, et al. Effects of apomorphine, a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia. Invest Ophthalmol Vis Sci. 1991;32:1674-1677.
15. Rohrer B, Spira AW, Stell WK. Apomorphine blocks formdeprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis Neurosci. 1993;10:447-453.
16. Iuvone PM, Tigges M, Fernandes A, Tigges J. Dopamine synthesis and metabolism in rhesus monkey retina: development, aging, and the effects of monocular visual deprivation. Vis Neurosci. 1989;2:465-471.
17. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res. 1991;52:755-758.
18. Feldkaemper MP, Schaeffel F. Evidence for a potential role of glucagon during eye growth regulation in chicks. Vis Neurosci. 2002;19:755-766.
19. Rohrer B, Stell WK. Basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGFb) act as stop and go signals to modulate postnatal ocular growth in the chick. Exp Eye Res. 1994;58:553-561.
20. Nickla DL, Wilken E, Lytle G, et al. Inhibiting the transient choroidal thickening response using the nitric oxide synthase inhibitor l-NAME prevents the ameliorative effects of visual experience on ocular growth in two different visual paradigms. Exp Eye Res. 2006;83:456-464.
21. McFadden SA, Howlett MH, Mertz JR, Wallman J. Acute effects of dietary retinoic acid on ocular components in the growing chick. Exp Eye Res. 2006;83:949-961.
22. Troilo D, Nickla DL, Mertz JR, Summers Rada JA. Change in the synthesis rates of ocular retinoic acid and scleral glycosaminoglycan during experimentally altered eye growth in marmosets. Invest Ophthalmol Vis Sci. 2006;47:1768-1777.
23. Mertz JR, Wallman J. Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth. Exp Eye Res. 2000;70:519-527.
24. Smith EL 3rd, Hung LF. Form-deprivation myopia in monkeys is a graded phenomenon. Vision Res. 2000; 40:371-381.
25. Smith EL 3rd, Hung LF, Kee CS, Qiao Y. Effects of brief periods of unrestricted vision on the development of formdeprivation myopia in monkeys. Invest Ophthalmol Vis Sci. 2002;43:291-299.
26. Smith EL 3rd, Hung LF, Huang J. Protective effects of high ambient lighting on the development of form-deprivation myopia in rhesus monkeys. Invest Ophthalmol Vis Sci. 2012;53: 421-428.
27. McCarthy CS, Megaw P, Devadas M, Morgan IG. Dopaminergic agents affect the ability of brief periods of normal vision to prevent form-deprivation myopia. Exp Eye Res. 2007;84:100-107.
28. Hoyt CS, Stone RD, Fromer C, Billson FA. Monocular axial myopia associated with neonatal eyelid closure in human infants. Am J Ophthalmol. 1981;91:197-200.
29. Morgan IG. The biological basis of myopic refractive error. Clin Exp Optom. 2003;86:276-288.
30. Wallman J, Adams JI. Developmental aspects of experimental myopia in chicks: susceptibility, recovery and relation to emmetropization. Vision Res. 1987;27:1139-1163.
31. Nathan J, Kiely PM, Crewther SG, Crewther DP. Diseaseassociated visual image degradation and spherical refractive errors in children. Am J Optom Physiol Opt. 1985;62:680-688.
32. Troilo D, Gottlieb MD, Wallman J. Visual deprivation causes myopia in chicks with optic nerve section. Curr Eye Res. 1987; 6:993-999.
33. Wallman J, Gottlieb MD, Rajaram V, Fugate-Wentzek LA. Local retinal regions control local eye growth and myopia. Science. 1987;237:73-77.
34. Gottlieb MD, Fugate-Wentzek LA, Wallman J. Different visual deprivations produce different ametropias and different eye shapes. Invest Ophthalmol Vis Sci. 1987; 28:1225-1235.
35. Guo SS, Sivak JG, Callendar MG, Diehl-Jones B. Retinal dopamine and lens-induced refractive error in chicks. Curr Eye Res. 1995;14:385-389.
36. Dowling JE, Ehinger B. Synaptic organization of the dopaminergic neurons in the rabbit retina. J Comp Neurol. 1978;180: 203-220.
37. Bloomfield SA, Vôlgyi B. The diverse functional roles and regulation of neuronal gap junctions in the retina. Nat Rev Neurosci. 2009;10:495-506.
38. Seeman P, Van Tol HHM. Dopamine receptor pharmacology. Trans Pharmacol Sci. 1994;15:264-270.
39. Pescosolido N, Parisi F, Russo P, et al. Role of dopaminergic receptors in glaucomatous disease modulation. Biomed Res Int. 2013; doi:10.1155/2013/193048.
40. Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res. 2013;114:106-119.
41. Schorderet M, Nowak JZ. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions. Cell Mol Neurobiol. 1990;10: 303-325.
42. Rohrer B, Stell W. Localization of putative dopamine D2-like receptors in the chick retina, using in situ hybridization and immunocytochemistry. Brain Res. 1995; 695:110-116.
43. Muresan Z, Besharse JC. D2-like dopamine receptors in amphibian retina: localization with fluorescent ligands. J Comp Neurol. 1993;331:149-160.
44. Cohen AI, Todd RD, Harmon S, O'Malley KL. Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci U S A. 1992;89:12093-12097.
45. Nguyen-Legros J, Simon A, Caille I, Bloch B. Immunocytochemical localization of dopamine D1 receptors in the retina of mammals. Vis Neurosci. 1997;14:545-551.
46. Veruki M. Dopaminergic neurons in the rat retina express dopamine D2/3 receptors. Eur J Neurosci. 1997;9:1096-1100.
47. Biedermann B, Frohlich E, Grosche J, et al. Mammalian Muller (glial) cells express functional D2 dopamine receptors. Neuroreport. 1995;6:609-612.
48. Wu DM, Kaamura H, Li Q, Puro DG. Dopamine activates ATPsensitive K+ currents in rat retinal pericytes. Vis Neurosci. 2001; 18:935-940.
49. Doyle SE, McIvor WE, Menaker M. Circadian rhythmicity in dopamine content of mammalian retina: role of the photoreceptors. J Neurochem. 2002;83:211-219.
50. Puopolo M, Hochstetler SE, Gustincich S, et al. Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation. Neuron. 2001;30:211-225.
51. Ko F, Seeman P, Sun WS, Kapur S. Dopamine D2 receptors internalize in their low-affinity state. Neuroreport. 2002;13: 1017-1020.
52. Nowak JZ, Sek B, Schorderet M. Dark-induced supersensitivity of dopamine D-1 and D-2 receptors in rat retina. Neuroreport. 1991;2:429-432.
53. Cahill GM, Besharse JC. Rhythmic regulation of retinal melatonin: metabolic pathways, neurochemical mechanisms, and the ocular circadian clock. Cell Mol Neurobiol. 1991;11:529-560.
54. Meyer P, Pache M, Loeffler KU, et al. MelatoninMT-1-receptor immunoreactivity in the human eye. Br J Ophthal. 2002;86: 1053-1057.
55. Nebbioso M, Scarsella G, Tafani M, Pescosolido N. Mechanisms of ocular neuroprotection by antioxidant molecules in animal models. J Biol Regul Homeost Agents. 2013;27:197-209.
56. Pescosolido N, Giannotti R, Plateroti AM, et al. Curcumin: therapeutical potential in ophthalmology. Planta Med 2014;80: 249-254.
57. Marchiafava PL, Longoni B. Melatonin as an antioxidant in retinal photoreceptors. J Pineal Res. 1999;26:184-189.
58. Fujieda H, Scher J, Hamadanizadeh SA, et al. Dopaminergic and GABAergic amacrine cells are direct targets of melatonin: immunocytochemical study of mt1 melatonin receptor in guinea pig retina. Vis Neurosci. 2000;17:63-70.
59. Dubocovich ML, Masana MI, Iacob S, Sauri DM. Melatonin receptor antagonists that differentiate between the humanMel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol. 1997;355: 365-375.
60. Besharse JC, Iuvone PM. Circadian clock in Xenopus eye controlling retinal serotonin N-acetyltransferase. Nature. 1983;305: 133-135.
61. Nao-i N, Gallemore RP, Steinberg RH. Effects of cAMP and IBMX on the chick retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990;31:68-80.
62. Rymer J, Wildsoet CF. The role of the retinal pigment epithelium in eye growth regulation and myopia: a review. Vis Neurosci. 2005;22:251-261.
63. Rohrer B, Spira AW, Stell WK. Apomorphine blocks formdeprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis Neurosci. 1993;10:447-453.
64. Nickla DL, Totonelly K, Dhillon B. Dopaminergic agonists that result in ocular growth inhibition also elicit transient increases in choroidal thickness in chicks. Exp Eye Res. 2010;91: 715-720.
65. Seko Y, Tanaka Y, Tokoro T. Apomorphine inhibits the growthstimulating effect of retinal pigment epithelium on scleral cells in vitro. Cell Biochem Funct. 1997;15:191-196.
66. Li XX, Schaeffel F, Kohler K, Zrenner E. Dose-dependent effects of 6-hydroxydopamine on deprivation myopia, electroretinograms, and dopaminergic amacrine cells in chickens. Vis Neurosci. 1992;9:483-492.
67. Schaeffel F, Bartmann M, Hagel G, Zrenner E. Studies on the role of the retinal dopamine/melatonin system in experimental refractive errors in chickens. Vision Res. 1995;35:1247-1264.
68. Schaeffel F, Hagel G, Bartmann M, Kohler K. 6-Hydoxy dopamine does not affect lens-induced refractive errors but suppresses deprivation myopia. Vision Res. 1994;34:143-149.
69. Schmid KL, Wildsoet C. Inhibitory effects of apomorphine and atropine and their combination on myopia in chicks. Optom Vis Sci. 2004;81:137-147.
70. Bartmann M, Schaeffel F, Hagel G, Zrenner E. Constant light affects retinal dopamine levels and blocks deprivation myopia but not lens-induced refractive errors in chickens. Vis Neurosci. 1994; 11:199-208.
71. Wildsoet C, Wallman J. Choroidal and scleral mechanisms of compensation for spectacle lenses in chicks. Vision Res. 1995; 35:1175-1194.
72. Kee CS, Marzani D, Wallman J. Differences in time course and visual requirements of ocular responses to lenses and diffusers. Invest Ophthalmol Vis Sci. 2001;42:575-583.
73. Gao Q, Liu Q, Ma P, et al. Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefes Arch Clin Exp Ophthalmol. 2006;244:1329-1335.
74. Mao J, Liu S, Qin W, et al. Levodopa inhibits the development of form-deprivation myopia in guinea pigs. Optom Vis Sci. 2010;87: 53-60.
75. Stone RA, Pendrak K, Sugimoto R, et al. Local patterns of image degradation differentially affect refraction and eye shape in chick. Curr Eye Res. 2006;31:91-105.
76. Philips SR, Robson AM. In vivo release of endogenous dopamine from rat caudate nucleus by phenylethylamine. Neuropharmacology. 1993;22:1297-1301.
77. Gropman AL. Patterns of brain injury in inborn errors of metabolism. Semin Pediatr Neurol. 2012;19:203-210.
78. Premont RT, Gainetdinov RR, Caron MG. Following the trace of elusive amines. Proc Natl Acad Sci U S A. 2001;98:9474-9475.
79. Xie Z, Miller GM. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain. J Pharmacol Exp Ther. 2008;325:617-628.
80. Scassellati C, Bonvicini C, Faraone SV, Gennarelli M. Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry. 2012;51:1003-1019.
81. Kusaga A, Yamashita Y, Koeda T, et al. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann Neurol. 2002;52:372-374.
82. Rho JM, Storey TW.Molecular ontogeny of major neurotransmitter receptor systems in the mammalian central nervous system: norepinephrine, dopamine, serotonin, acetylcholine, and glycine. J Child Neurol. 2001;16:271-281.
83. Goldstein DS, Holmes C, Sato T, et al. Central dopamine deficiency in pure autonomic failure. Clin Auton Res. 2008;18:58-65.
84. Liu B.Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease. AAPS J. 2006;8: E606-E621.
85. Janssen PA, Leysen JE, Megens AA, Awouters FH. Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol. 1999;2:229-240.
86. Gao J, Liu ZJ, Chen T, Zhao D. Pharmaceutical properties of calycosin, the major bioactive isoflavonoid in the dry root extract of Radix astragali. Pharm Biol. 2014 Mar 17.
87. Romay C, González R. Phycocyanin is an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. J Pharm Pharmacol. 2000;52:367-368.
88. Jarratt CJ, Jewett MD, Peters S, Tragash E. The Children and Algae Report. Center for Family Wellness Study, 1995.